- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/14 - Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus
Patent holdings for IPC class C07K 14/14
Total number of patents in this class: 108
10-year publication summary
|
6
|
9
|
5
|
6
|
10
|
10
|
3
|
2
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oncolytics Biotech Inc. | 49 |
8 |
| Novartis AG | 10883 |
5 |
| Intervet International B.V. | 1275 |
5 |
| Intervet Inc. | 896 |
4 |
| Universidade de Santiago de Compostela | 314 |
4 |
| The Regents of the University of California | 19839 |
3 |
| Gavish-galilee Bio Applications Ltd. | 48 |
3 |
| Medicago Inc. | 138 |
3 |
| Merial Limited | 117 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 578 |
3 |
| Modernatx, Inc. | 1260 |
3 |
| North Carolina State University | 1554 |
3 |
| University of Georgia Research Foundation, Inc. | 1019 |
3 |
| Entos Pharmaceuticals Inc. | 38 |
3 |
| BRANDEIS University | 333 |
2 |
| Children's Medical Center Corporation | 1853 |
2 |
| London School of Hygiene & Tropical Medicine | 25 |
2 |
| Osaka University | 3367 |
2 |
| The Trustees of Indiana University | 726 |
2 |
| University of Cape Town | 258 |
2 |
| Other owners | 43 |